USPQ 90, 96 (Fed.Cir.1985), but we presume that the jury resolved underlying evi-dentiary conflicts in Wilson’s favor, see DMI, Inc. v. Deere & Co., 802 F.2d 421, 425, 231 USPQ 276, 279 (Fed.Cir.1986).
This court on occasion has characterized claims as being “expanded” or “broadened” under the doctrine of equivalents. See, e.g., Intervet America v. Kee-Vet Laboratories, 887 F.2d 1050, 1054, 12 USPQ2d 1474, 1477 (literal meaning of claim is expanded under the doctrine of equivalents); Brenner v. United States, 773 F.2d 306, 308, 227 USPQ 159, 161 (Fed.Cir.1985) (describing doctrine of equivalents as “broadening” claims); Thomas & Betts Corp. v. Litton Sys., Inc., 720 F.2d 1572, 1582, 220 USPQ 1, 7 (Fed.Cir.1983) (claims have a “broadened scope”); Carman Indus., Inc. v. Wahl, 724 F.2d 932, 942, 220 USPQ 481, 489 (Fed.Cir.1983) (“Even with this expansion in the scope of the claims ... ”). Precisely speaking, these characterizations are inaccurate.
To say that the doctrine of equivalents extends or enlarges the claims is a contradiction in terms. The claims — i.e., the scope of patent protection as defined by the claims — remain the same and application of the doctrine expands the right to exclude to “equivalents” of what is claimed.
The doctrine of equivalents, by definition, involves going beyond any permissible interpretation of the claim language; i.e., it involves determining whether the accused product is “equivalent” to what is described by the claim language.
This distinction raises an interesting question: If the doctrine of equivalents does not involve expanding the claims, why should the
prior art be a limitation on the range of permissible equivalents? It is
not because we construe claims narrowly if necessary to sustain their validity.
E.g., Lewmar Marine, Inc. v. Barient, Inc., 827 F.2d 744, 749, 3 USPQ2d 1766, 1770 (Fed.Cir.1987). As we have said, the doctrine of equivalents does not involve expansion of the
claims. Nor is it because to hold otherwise would allow the patentee to preempt a product that was in the public domain prior to the invention. The accused products here, as in most infringement cases, were never “in the public domain.” They were developed long after the invention and differ in several respects from the prior art.
The answer is that a patentee should not be able to obtain, under the doctrine of equivalents, coverage which he could not lawfully have obtained from the PTO by literal claims. The doctrine of equivalents exists to prevent a fraud on a patent, Graver Tank & Mfg. Co. v. Linde Air Prods. Co., 339 U.S. 605, 608, 70 S.Ct. 854, 856, 94 L.Ed. 1097 (1950), not to give a patentee something which he could not lawfully have obtained from the PTO had he tried. Thus, since prior art always limits what an inventor could have claimed, it limits the range of permissible equivalents of a claim.
Whether prior art restricts the range of equivalents of what is literally claimed can be a difficult question to answer. To simplify analysis and bring the issue onto familiar turf, it may be helpful to conceptualize the limitation on the scope of equivalents by visualizing a hypothetical patent claim, sufficient in scope to literally cover the accused product. The pertinent question then becomes whether that hypothetical claim could have been allowed by the PTO over the prior art. If not, then it would be improper to permit the patentee to obtain that coverage in an infringement suit under the doctrine of equivalents. If the hypothetical claim could have been allowed, then prior art is not a bar to infringement under the doctrine of equivalents.
Viewing the issue in this manner allows use of traditional patentability rules and permits a more precise analysis than determining whether an
accused product (which has no claim limitations on which to focus) would have been obvious in view of the prior art.
Compare with Ryco, Inc. v. Ag-Bag Corp., 857 F.2d 1418, 1426, 8 USPQ2d 1323, 1330 (Fed.Cir.1988) (comparing accused product with prior art). In fact, the utility of this hypothetical broader